Preventing disordered eating patterns during the transition Stopping GLP-1s can increase vulnerability to restrictive eating, binge-restrict cycles, purging, emotional eating, or relapse into past eating disorder behaviors
8 , bvae164 (2024)
Jun 27, 2024 | Blog, Diet, Nutrition Why Am I Not Losing Weight on Semaglutide
It was approved by the FDA in September 2014 to improve blood sugar control in adults with Type 2 diabetes
First dose, increasing Ozempic dose, and side effects The most commonly reported side effects were related to the stomach and digestion
For patients, this distinction means branded products carry FDA-tested stability data and formal adverse event monitoring, while compounded options may offer cost savings and access to qualified providers in states with robust compounding oversight